RubrYc Therapeutics

RubrYc Therapeutics, Inc., is a biotechnology company applying proprietary machine-learning and computational biology solutions to discover epitope-selective mono and bispecific antibodies. The company was founded in 2017 and is headquartered in San Carlos, California.